NDC Package 55289-266-30 Evista

View Billable Units, 11-Digit Format, RxNorm

Package Information
Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory .

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

55289-266-30

Package Description:

30 TABLET in 1 BOTTLE, PLASTIC

Product Code:

55289-266

Proprietary Name:

Evista

Usage Information:

Raloxifene is used by women to prevent and treat bone loss (osteoporosis) after menopause. It slows down bone loss and helps to keep bones strong, making them less likely to break. Raloxifene may also lower the chance of getting a certain type of breast cancer (invasive breast cancer) after menopause. Raloxifene is not an estrogen hormone, but it acts like estrogen in some parts of the body, like your bones. In other parts of the body (uterus and breasts), raloxifene acts like an estrogen blocker. It does not relieve menopause symptoms such as hot flashes. Raloxifene belongs to a class of drugs known as selective estrogen receptor modulators-SERMs. This medication should not be used before menopause. It should not be used to prevent heart disease.

11-Digit NDC Billing Format:

55289026630

Billing Unit:

EA - Billing unit of "each" is used when the product is dispensed in discreet units.

NDC to RxNorm Crosswalk:

30 EA

Labeler Name:

Pd-rx Pharmaceuticals, Inc.

Sample Package:

FDA Application Number:

NDA020815

Marketing Category:

NDA - A product marketed under an approved New Drug Application.

Start Marketing Date:

01-06-1998

End Marketing Date:

07-17-2018

Listing Expiration Date:

07-17-2018

Exclude Flag:

Code Structure:

55289 - Pd-rx Pharmaceuticals, Inc.
- 55289-266 - Evista
  - 55289-266-30 - 30 TABLET in 1 BOTTLE, PLASTIC

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 55289-266-30?

The NDC Packaged Code 55289-266-30 is assigned to a package of 30 tablet in 1 bottle, plastic of Evista, labeled by Pd-rx Pharmaceuticals, Inc.. The product's dosage form is and is administered via form.This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package.

Is NDC 55289-266 included in the NDC Directory?

The product was first marketed by Pd-rx Pharmaceuticals, Inc. on January 06, 1998 and its listing in the NDC Directory is set to expire on July 17, 2018 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 55289-266-30?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 30.

What is the 11-digit format for NDC 55289-266-30?

The 11-digit format is 55289026630. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-3-2	55289-266-30	5-4-2	55289-0266-30

Table of Contents